The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
September 21, 2016
Medicaid The Center for Evidence-based Policy
Back to News and Updates
The Center for Evidence-based Policy (CEbP) is making progress on SMART-D, the State Medicaid Alternative Reimbursement and Purchasing Test for High-Cost Drugs. Earlier this month, the SMART-D group released a report examining the landscape of Medicaid drug purchasing, specifically focusing on state Medicaid programs’ ability to pursue alternative payment models. The SMART-D Summary Report suggests that multiple opportunities exist to help improve patient access to evidence-based therapies while allowing states to predict and manage prescription drug costs. A new website, Smart-D.org, was also launched
“Today’s payment landscape is especially challenging for state Medicaid programs, which are struggling to balance budgets as more and more innovative treatments become available, often at a higher cost,” said Pam Curtis, director of CEbP. “This research can help achieve the triple win of maintaining access to treatments for Medicaid enrollees while also ensuring that drug manufacturers are reimbursed and states manage costs as effectively as possible.”
The Center is a strategic partner of the Milbank Memorial Fund (MMF); the two organizations collaborate on promoting the development of evidence-informed health policymaking capacity in states. MMF is assisting SMART-D with staff support, strategic counsel, and advisory-board convening. “Access to affordable prescription drugs is a key policy issue for states,” said Christopher F. Koller, president of MMF. “The SMART-D report is an authoritative overview of prescription drug programs in Medicaid and options for states to get more value for their enrollees.”
Now that Phase I of the project is complete, the SMART-D group plans to move forward with Phase II, which will involve working with several states to explore opportunities to collaborate with drug manufacturers and providing implementation and technical assistance to states.
Sep 23, 2020
Sep 15, 2020
Sep 8, 2020
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.